We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Multiplex Diagnostics System Enables Rapid Detection of Multiple Pathogens

By LabMedica International staff writers
Posted on 04 Dec 2024

Each year, the World Health Organization (WHO) releases its Compendium of Innovative Health Technologies for Low-resource Settings, which highlights commercially available solutions and prototypes designed to tackle the challenges faced by low- and middle-income countries in accessing effective, safe, and affordable health technologies. More...

These technologies are crucial in addressing infectious diseases and the growing burden of non-communicable diseases such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes. The WHO’s 2024 Compendium has recommended a novel automated multiplex diagnostics system as an innovative technology with significant potential to support health systems in these regions.

Developed at Hong Kong Baptist University (HKBU, Kowloon Tong, Hong Kong), the Automated Multiplex Diagnostics System recommended by the WHO’s 2024 Compendium offers a fully automated solution for conventional laboratory-based PCR (polymerase chain reaction) processes. The system consists of three integrated components: an analytical machine, a microfluidic reagent cartridge, and software. Its unique design enables the detection of 42 respiratory pathogens—28 viruses, 11 bacteria, and 3 fungi—in less than 1.5 hours, without requiring a resource-heavy laboratory, specialized equipment, or highly trained technicians, while ensuring high sensitivity and specificity.

In addition to its impressive performance, the system also offers several advantages in terms of cost-effectiveness, reduced turnaround time, and the ability to analyze multiple targets simultaneously. The system, created by a research team led by Professor Terence Lau from HKBU, is featured as one of 21 highlighted health technologies in the WHO’s 2024 Compendium under the prototype category. The concept for a fully automated, rapid, accurate, and affordable multiplex pathogen detection device was conceived in 2015, and its capabilities were expanded to support the detection of 40 targets, including SARS-CoV-2, in response to the urgent demand for decentralized diagnostics during the COVID-19 pandemic in 2020.

"The System can identify infectious diseases and even non-communicable diseases, and is suitable for other non-medical applications," said Professor Lau. "With this System, we will be able to provide a comprehensive solution that can eventually promote equitable access and decentralized testing for an effective and high-quality healthcare system which WHO emphasizes."

Related Links:
HKBU 


New
Gold Member
Hematology Analyzer
Medonic M32B
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Gold Member
Hematology System
Medonic M16C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.